PF-06482077LPF-06928316
- Generic Name
- PF-06482077LPF-06928316
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 550
- Registration Number
- NCT06866405
- Locations
- πΊπΈ
Advanced Specialty Research, Boise, Idaho, United States
πΊπΈSaint Alphonsus Regional Medical Center, Boise, Idaho, United States
πΊπΈVelocity Clinical Research - New Orleans, New Orleans, Louisiana, United States
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
- Conditions
- Healthy Participants
- Interventions
- Biological: Combination [RSVpreF+BNTb162b2]Biological: Bivalent BNT162b2 (original/Omi BA.4/BA.5)Biological: QIVBiological: Normal Saline Placebo
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1142
- Registration Number
- NCT05886777
- Locations
- πΊπΈ
DM Clinical Research, Martin Diagnostic Clinic, Tomball, Texas, United States
πΊπΈWest Coast Research, Dublin, California, United States
πΊπΈMarvel Clinical Research, Huntington Beach, California, United States
A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults
- Conditions
- Healthy
- Interventions
- Biological: RSVpreF+qIRVBiological: RSVpreF + qIRV 1.0 mL formulationDrug: PlaceboBiological: RSVpreF + qIRV 0.5 mL formulation
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 508
- Registration Number
- NCT05788237
- Locations
- π¦π·
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
- Conditions
- Lower Respiratory Tract Illness
- Interventions
- Biological: Placebo
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 38567
- Registration Number
- NCT05035212
- Locations
- πΊπΈ
St. Vincent's Birmingham (Pharmacy), Birmingham, Alabama, United States
πΊπΈSt. Vincent's Birmingham, Birmingham, Alabama, United States
πΊπΈMedical Affiliated Research Center, Huntsville, Alabama, United States
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
- Conditions
- Respiratory Tract Infection
- Interventions
- Biological: Placebo
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14727
- Registration Number
- NCT04424316
- Locations
- πΊπΈ
Pocatello Women's Health Clinic, Pocatello, Idaho, United States
πΊπΈ1st Choice Urgent Care, Pocatello, Idaho, United States
πΊπΈThe Iowa Clinic, Ankeny, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.